Morgenthaler Ventures logo

Morgenthaler Ventures

North America, California, United States, Menlo Park

Description

Morgenthaler Ventures was a venerable venture capital and private equity firm with a rich history spanning over five decades, having been founded in 1968. Based in Menlo Park, California, the firm established itself as a significant player in the technology and life sciences sectors, known for its early-stage investments. Over its operational history, Morgenthaler Ventures made a substantial impact, participating in 282 investments and achieving 108 exits, including highly successful companies like Siri (acquired by Apple), Evernote, LendingClub, MuleSoft, and Docusign. The firm managed substantial capital, with its last reported fund, Morgenthaler Partners X, closing in 2008 with $400 million.

In a strategic move, Morgenthaler Ventures ceased active new investments as a unified entity. Its specialized teams spun out to form independent venture capital firms. The early-stage IT investment team transitioned to establish Canvas Ventures, focusing on new technology opportunities. Concurrently, the healthcare investment team formed Lightstone Ventures, continuing to pursue opportunities within the life sciences sector. This restructuring allowed the specialized teams to operate with greater autonomy and focus on their respective domains, building upon the legacy and expertise cultivated at Morgenthaler Ventures.

Given that Morgenthaler Ventures itself is no longer actively making new investments, its historical typical first check sizes are not directly applicable to current market opportunities. The firm's focus was primarily on early-stage companies, often participating in Seed to Series B rounds. While specific historical check sizes are not publicly detailed for every investment, their participation in numerous early rounds and their substantial fund sizes suggest investments ranging from several hundreds of thousands to multi-million dollar figures, depending on the stage and capital requirements of the portfolio companies. For current investment inquiries, prospective companies should instead approach Canvas Ventures or Lightstone Ventures, depending on their sector.

Investor Profile

Morgenthaler Ventures has backed more than 324 startups, with 1 new investments in the last 12 months alone. The firm has led 49 rounds, about 15% of its total and boasts 105 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Series B (24%)
  • Series Unknown (22%)
  • Series A (18%)
  • Series C (18%)
  • Series D (10%)
  • Series E (3%)
  • Post Ipo Equity (1%)
  • Series G (1%)
  • Series F (1%)
  • Seed (1%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Manufacturing
  • Software
  • Medical Device
  • Enterprise Software
  • Information Technology
  • Therapeutics
  • Telecommunications
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Morgenthaler Ventures frequently co-invest with?

Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 19
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 34
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 17
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 16
Hummer Winblad Venture Partners
North America, California, United States, San Francisco
Co-Investments: 20
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 26
Split Rock Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 19
Advanced Technology Ventures
North America, California, United States, Menlo Park
Co-Investments: 22
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 14
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 15

Which angels does Morgenthaler Ventures often collaborate with?

AK
North America, California, United States, San Francisco
Shared Deals: 1
AP
North America, California, United States, San Francisco
Shared Deals: 2
SB
North America, California, United States, San Francisco
Shared Deals: 2
JK
North America, California, United States, San Francisco
Shared Deals: 1
GC
North America, California, United States, San Francisco
Shared Deals: 1
Matthew Winkler
North America, Texas, United States, Austin
Shared Deals: 1
HP
North America, Washington, United States, Bellevue
Shared Deals: 2
AH
North America, California, United States, San Francisco
Shared Deals: 2
FN
North America, California, United States, Menlo Park
Shared Deals: 1
RC
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Morgenthaler Ventures?

Moximed

Hayward, California, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

BiotechnologyHealth CareMedical Device
Series DAug 13, 2024
Amount Raised: $61,000,000
Relievant Medsystems

Minneapolis, Minnesota, United States

Relievant Medsystems is a medical device company specializing in diagnosing and treating chronic low back pain.

BiotechnologyHealth CareMedical
Series GMar 27, 2023
Amount Raised: $50,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 19, 2023
Amount Raised: $80,000,000
Moximed

Hayward, California, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

BiotechnologyHealth CareMedical Device
Series CAug 16, 2022
Amount Raised: $40,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 27, 2021
Amount Raised: $64,000,000
Relievant Medsystems

Minneapolis, Minnesota, United States

Relievant Medsystems is a medical device company specializing in diagnosing and treating chronic low back pain.

BiotechnologyHealth CareMedical
Series FOct 29, 2020
Amount Raised: $70,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownSep 18, 2019
Amount Raised: $15,700,000
Nuvaira

Minneapolis, Minnesota, United States

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.

BiotechnologyHealth CareInformation TechnologyMedical Device
Series EFeb 11, 2019
Amount Raised: $79,000,000
NuoDB

Cambridge, Massachusetts, United States

NuoDB is a provider of distributed SQL database for cloud applications.

Cloud Data ServicesDatabaseEnterprise SoftwareSoftware
Series UnknownDec 31, 2018
Amount Raised: $30,551,531
Vapotherm

Exeter, New Hampshire, United States

Vapotherm is a medical device company that develops a mask-free respiratory support tool.

BiotechnologyHealth CareManufacturingMedical Device
Series DSep 1, 2018
Amount Raised: $10,000,000